India has set an ambitious timeline for its first potential coronavirus vaccine -- from human trials to general use in six weeks.
Bharat Biotech International Ltd., an unlisted Indian vaccine maker, received the regulatory nod to start human clinical trials for its experimental shot only earlier this week but it already has...
India’s First COVID-19 Vaccine Could Meet Mid-August Target
Eurasia Review
0 shares
1 views
You might like
Related news coverage
Australia: Decoding Cyberattack – Analysis
Eurasia Review
By Kritika Roy*
The sudden outbreak of COVID-19 has led to increased use of digital platforms as primary modes of..
-
FTSE 100 clinging on to gains as sterling rallies
Proactive Investors
-
FTSE 100 shrugs off latest episode in US-China muscle-flexing contest
Proactive Investors
-
NA Proactive news snapshot: Ipsidy, Avalon GloboCare, BioSig Technologies, Co-Diagnostics, Black Iron, Thunderbird Entertainment UPDATE …
Proactive Investors
-
No COVID-19 vaccine before 2021's first quarter, Parliamentary panel told
Mid-Day
Advertisement
More coverage
News24.com | India’s first Covid-19 vaccine races to meet August target
News24
Bharat Biotech International received regulatory approval to start human clinical trials for its experimental shot earlier this..
-
WHO says Sri Lanka and Maldives eliminate measles, rubella
SeattlePI.com
-
COVID-19: Maharashtra hotels to reopen, 50 percent may shut for good
Mid-Day
-
ICMR: Fast-track clinical trials, need to launch vaccine for COVID-19 by August 15
Mid-Day
-
Today's Market View - Ariana Resources, Bushveld Minerals, Eurasia Mining, Greatland Gold and others
Proactive Investors